Manufacturing and Production

Showing 15 posts of 5867 posts found.

stocks1

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

November 27, 2018 Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …
nhs_sign

NHS to save £300 million by switching to Humira biosimilars

November 27, 2018 Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma

NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …
bmssyracuseny

BMS’ Opdivo+Yervoy combo fails in small cell lung cancer

November 27, 2018 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Cancer, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed that its combo comprising Opdivo (nivolumab) and Yervoy (ipilimumab) failed to meet its primary endpoint as …
fda2outsideweb

FDA approves first oral TRK inhibitor with Loxo Oncology’s Vitrakvi

November 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, FDA, Loxo Oncology, Vitrakvi, oncology, pharma

The FDA has announced the approval of the United States’ first-ever oral tyrosine kinase (TRK) inhibitor, Loxo Oncology’s Vitrakvi (larotrectinib), …
sunpharma

Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk

November 26, 2018 Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma

Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …

Uninsured patients elibible for no-cost replacement of medicines lost in California wildfires

November 22, 2018 Manufacturing and Production, Sales and Marketing USA, california, insurance, prescription, wildfires

Uninsured citizens in California’s Butte, Los Angeles and Ventura counties will be eligible for a no-cost replacement of medicines lost …

First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee

November 20, 2018 Manufacturing and Production, Sales and Marketing CHMP, EMA, Europe, Sanofi, fexinidazole, pharma, sleeping sickness

Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …
shutterstock_138095450

Opioid dependency therapy price hiked 600% since 2014, Senate investigators find

November 20, 2018 Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma

Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …
shutterstock_159488225

Merck KGaA and Pfizer’s Bavencio falls short in ovarian cancer

November 20, 2018 Manufacturing and Production, Research and Development Bavencio, Cancer, Merck MGaA, Pfizer, ovarian cancer, pharma

Merck KGaA and Pfizer’s Bavencio (avelumab) has missed its primary endpoints in the treatment of platinum-resistant or -refractory ovarian cancer, …

Pfizer to resume price hiking in 2019; 41 drugs set to increase

November 20, 2018 Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing

American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …
lilly_entrance_web

Eli Lilly’s Emgality cleared for treatment of migraine in Europe

November 20, 2018 Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma

Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …
arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
david_wehner

Alector strengthens board with three appointments including Facebook CFO David Wehner

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
The Gateway to Local Adoption Series

Latest content